Transcat (NASDAQ:TRNS) CEO Jaime Irick Acquires 2,275 Shares of Stock

Transcat, Inc. (NASDAQ:TRNS) CEO Jaime Irick bought 2,275 shares of the stock in a transaction on Thursday, November 5th. The shares were acquired at an average cost of $101.26 per share, for a total transaction of $230,366.50. Following the completion of the transaction, the chief executive officer directly owned 2,275 shares of the company’s stock, valued at approximately $230,366.50. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Transcat Stock Up 1.1%

NASDAQ TRNS traded up $1.13 during trading on Friday, hitting $101.51. 169,759 shares of the company traded hands, compared to its average volume of 135,380. Transcat, Inc. has a 12 month low of $50.23 and a 12 month high of $110.47. The business has a fifty day simple moving average of $86.94 and a 200 day simple moving average of $82.43. The company has a current ratio of 2.49, a quick ratio of 2.11 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $953.18 million, a P/E ratio of 211.48 and a beta of 0.61.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.19. The company had revenue of $97.09 million during the quarter, compared to the consensus estimate of $92.46 million. Transcat had a return on equity of 5.56% and a net margin of 0.99%. As a group, sell-side analysts predict that Transcat, Inc. will post 2.06 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on TRNS shares. Northland Securities raised Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price for the company in a research report on Wednesday, October 21st. Weiss Ratings reissued a “sell (d+)” rating on shares of Transcat in a research report on Tuesday, August 25th. CJS Securities started coverage on shares of Transcat in a research note on Tuesday, October 27th. They issued an “outperform” rating and a $115.00 price objective for the company. Finally, Oppenheimer raised shares of Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 price objective for the company in a report on Wednesday. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $108.33.

More Transcat News

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Zacks upgraded Transcat to Rank #1 (Strong Buy), citing improving earnings prospects, and included TRNS on its Strong Buy momentum-stock list. Zacks Strong Buy upgrade
• Positive Sentiment: Northland Securities raised its EPS forecasts across 2027–2031, including lifting its FY2027 estimate to $2.00 from $1.71 and its FY2031 estimate to $3.69 from $3.53. The revisions suggest stronger expected earnings growth. Northland estimate revisions
• Positive Sentiment: Oppenheimer raised its rating on Transcat to Outperform, adding to the favorable analyst sentiment. Oppenheimer rating upgrade
• Positive Sentiment: Recent coverage linked TRNS reaching a 52-week high to an earnings beat and improved outlook. The supplied background also reports quarterly EPS of $0.64 versus a $0.45 consensus estimate, with revenue above forecasts. Transcat 52-week high following earnings beat
• Neutral Sentiment: Northland maintained an Outperform rating but set a $95 price target, below the $101.32 share price cited in the background; this may temper the impact of its higher earnings forecasts. Northland rating and target

Hedge Funds Weigh In On Transcat

Large investors have recently made changes to their positions in the business. Integrated Wealth Concepts LLC acquired a new stake in Transcat in the 2nd quarter valued at approximately $32,000. Persistent Asset Partners Ltd acquired a new position in shares of Transcat during the second quarter worth approximately $52,000. GAMMA Investing LLC boosted its position in shares of Transcat by 133.6% in the third quarter. GAMMA Investing LLC now owns 1,030 shares of the scientific and technical instruments company’s stock valued at $91,000 after acquiring an additional 589 shares during the period. Squarepoint Ops LLC boosted its position in shares of Transcat by 9.0% in the second quarter. Squarepoint Ops LLC now owns 8,794 shares of the scientific and technical instruments company’s stock valued at $816,000 after acquiring an additional 728 shares during the period. Finally, Corient Private Wealth LP grew its stake in shares of Transcat by 9.1% in the second quarter. Corient Private Wealth LP now owns 9,509 shares of the scientific and technical instruments company’s stock worth $882,000 after acquiring an additional 791 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

About Transcat

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.